SFERA Archivio dei prodotti della Ricerca dell'Università di Ferrara

MARCONI, Peggy Carla Raffaella
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 12.428
AS - Asia 6.238
EU - Europa 3.596
SA - Sud America 990
Continente sconosciuto - Info sul continente non disponibili 236
AF - Africa 140
OC - Oceania 13
Totale 23.641
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 12.117
SG - Singapore 2.289
CN - Cina 1.484
IT - Italia 857
BR - Brasile 748
VN - Vietnam 667
UA - Ucraina 543
HK - Hong Kong 524
GB - Regno Unito 463
DE - Germania 420
PL - Polonia 351
TR - Turchia 343
BD - Bangladesh 274
FR - Francia 224
FI - Finlandia 193
JP - Giappone 185
CA - Canada 147
RU - Federazione Russa 147
IN - India 115
MX - Messico 101
SE - Svezia 97
AR - Argentina 92
ID - Indonesia 89
NL - Olanda 79
ZA - Sudafrica 61
ES - Italia 49
IQ - Iraq 46
CO - Colombia 40
PK - Pakistan 40
EC - Ecuador 32
BE - Belgio 30
AT - Austria 28
UZ - Uzbekistan 27
VE - Venezuela 23
LT - Lituania 22
MY - Malesia 22
CL - Cile 20
SA - Arabia Saudita 19
MA - Marocco 18
JM - Giamaica 17
PH - Filippine 17
PY - Paraguay 17
IE - Irlanda 16
AE - Emirati Arabi Uniti 15
CZ - Repubblica Ceca 14
AU - Australia 13
CH - Svizzera 12
CR - Costa Rica 11
NP - Nepal 11
UY - Uruguay 10
ET - Etiopia 9
PA - Panama 9
PT - Portogallo 9
AL - Albania 8
KE - Kenya 8
AZ - Azerbaigian 7
DZ - Algeria 7
EG - Egitto 7
IL - Israele 7
IR - Iran 7
TN - Tunisia 7
JO - Giordania 6
GE - Georgia 5
HN - Honduras 5
KR - Corea 5
MD - Moldavia 5
NO - Norvegia 5
OM - Oman 5
BB - Barbados 4
BO - Bolivia 4
LB - Libano 4
RO - Romania 4
TH - Thailandia 4
GT - Guatemala 3
KW - Kuwait 3
KZ - Kazakistan 3
MZ - Mozambico 3
NI - Nicaragua 3
PE - Perù 3
SK - Slovacchia (Repubblica Slovacca) 3
SN - Senegal 3
TW - Taiwan 3
AO - Angola 2
BY - Bielorussia 2
CG - Congo 2
EE - Estonia 2
EU - Europa 2
GD - Grenada 2
GH - Ghana 2
HR - Croazia 2
KG - Kirghizistan 2
MM - Myanmar 2
MN - Mongolia 2
NG - Nigeria 2
PR - Porto Rico 2
RE - Reunion 2
RS - Serbia 2
SI - Slovenia 2
SY - Repubblica araba siriana 2
TG - Togo 2
Totale 23.383
Salva come PNG Salva come JPEG
Città #
Ashburn 1.562
Singapore 1.496
Fairfield 1.049
Woodbridge 1.035
San Jose 806
Houston 614
Jacksonville 560
Santa Clara 518
Hong Kong 512
Chandler 498
Beijing 477
Ann Arbor 437
Seattle 419
New York 376
Wilmington 363
Cambridge 338
Warsaw 338
Ferrara 224
Ho Chi Minh City 212
Los Angeles 211
Dallas 207
Izmir 188
Council Bluffs 180
Tokyo 172
Hanoi 166
Nanjing 149
Princeton 135
Lauterbourg 133
San Diego 108
Munich 104
Milan 93
São Paulo 88
Buffalo 67
Shanghai 67
Mexico City 61
Jakarta 59
Bologna 56
Tianjin 55
Boardman 54
Orem 53
Shenyang 53
Chicago 50
Montreal 48
Brooklyn 47
Toronto 46
Helsinki 43
The Dalles 43
London 42
Rome 42
Turku 39
Hebei 37
Hefei 37
Poplar 35
Chennai 34
Jiaxing 34
Atlanta 33
Da Nang 33
Nanchang 32
Johannesburg 31
Frankfurt am Main 30
Brussels 29
Phoenix 29
San Francisco 29
Stockholm 29
Changsha 28
Moscow 27
Boston 24
Manchester 24
Washington 24
Denver 22
Falls Church 22
Haiphong 22
Tashkent 22
Naples 20
Guangzhou 19
Norwalk 19
Rio de Janeiro 19
Vienna 19
Amsterdam 18
Falkenstein 18
Mountain View 18
Baghdad 17
Brasília 16
Dublin 16
Ningbo 16
Redwood City 16
New Delhi 15
San Mateo 15
Ankara 14
Dong Ket 14
Jinan 14
Kingston 14
Kunming 14
Lahore 14
Nuremberg 14
Zhengzhou 14
Auburn Hills 13
Medellín 13
Newark 13
Orange 13
Totale 15.785
Salva come PNG Salva come JPEG
Nome #
Novel tumour-specific promoters for transcriptional targeting of hepatocellular carcinoma by herpes simplex virus vectors 334
Characterization of herpes simplex virus 1 strains as platforms for the development of oncolytic viruses against liver cancer 281
The HIV-1 Tat protein induces the activation of CD8+ T cells and affects in vivo the magnitude and kinetics of antiviral responses. 275
Antitumor effects of non-replicative herpes simplex vectors expressing antiangiogenic proteins and thymidine kinase on Lewis lung carcinoma establishment and growth. 271
CD40-signalling abrogates induction of RORγt+ Treg cells by intestinal CD103+ DCs and causes fatal colitis 271
An Attenuated Herpes Simplex Virus Type 1 (HSV1) Encoding the HIV-1 Tat Protein Protects Mice from a Deadly Mucosal HSV1 Challenge 268
Systemic immunodominant CD8 responses with an effector-like phenotype are induced by intravaginal immunization with attenuated HSV vectors expressing HIV Tat and mediate protection against HSV infection 262
Hippocampal FGF-2 and BDNF overexpression attenuates epileptogenesis-associated neuroinflammation and reduces spontaneous recurrent seizures. 248
Effects of defective herpes simplex vectors expressing neurotrophic factors on the proliferation and differentiation of nervous cells in vivo 244
Herpetic vectors inhibiting angiogenesis and inducing cell suicide in gliomas 238
Recombinant herpes simplex virus and uses therefor 237
A direct gene transfer strategy via brain internal capsule reverses the biochemical defect in Tay-Sachs disease 229
Herpesvirus-based vectors for gene transfer, gene therapy and the development of novel vaccines 228
Control of Erwinia amylovora Growth by Moringa oleifera Leaf Extracts: In Vitro and in Planta Effects 223
HSV as a vector in vaccine development and gene therapy 219
Sustainable vs. Conventional Cleaning in Healthcare: Microbiological and Life Cycle Insights 216
Botulinum neurotoxin light chains expressed by defective herpes simplex virus type-1 vectors cleave snare proteins and inhibit cgrp release in rat sensory neurons 212
HSV-1-derived recombinant and amplicon vectors for gene transfer and gene therapy 205
Herpesvirus-based vaccines 205
Capitolo 55 Retrovirus 203
Age-related decline of de novo T cell responsiveness as a cause of COVID-19 severity 203
Localized overexpression of FGF-2 and BDNF in hippocampus reduces mossy fiber sprouting and spontaneous seizures up to 4 weeks after pilocarpine-induced status epilepticus 201
Fibroblast growth factor-II gene therapy reverts the clinical course and the pathological signs of chronic experimental autoimmune encephalomyelitis in C57BL/6 mice 197
Inhibition of HIV-1 replication and reactivation from latency by tat transdominant negative mutants in the cysteine rich region 197
Central nervous system gene therapy with interleukin-4 inhibits progression of ongoing relapsing-remitting autoimmune encephalomyelitis in Biozzi AB/H mice 195
Impaired Priming of SARS-CoV-2-Specific Naive CD8+ T Cells in Older Subjects 195
Effects of Moringa oleifera Leaf Extracts on Xanthomonas campestris pv. campestris 194
Herpes Simplex Virus Growth, Preparation, and Assay 193
HSV as a vector in vaccine development and gene therapy 193
Generation of a human induced pluripotent stem cell line (UNIFEi001-A) from a patient with Spinocerebellar ataxia type 1 (SCA1) 192
Inhibition of HIV-1 replication by a Tat transdominant negative mutant in human peripheral blood lymphocytes from healthy donors and HIV-1-infected patients 192
Development and application of replication-incompetent HSV-1-based vectors 191
HSV vector cytotoxicity is inversely correlated with effective TK/GCV suicide gene therapy of rat gliosarcoma 187
Temporal lobe epilepsy model, neural stem cells and gene therapy 187
Intranasal immunization in mice with non-ionic surfactants vesicles containing HSV immunogens: a preliminary study as possible vaccine against genital herpes 186
Protection from bacterial infection by a single vaccination with replication-deficient mutant herpes simplex virus type 1 185
Herpes simplex virus type 1 infects enteric neurons and triggers gut dysfunction via macrophage recruitment 184
Purinergic Signaling: A New Pharmacological Target Against Viruses? 184
Herpes simplex virus type 1 and Alzheimer’s disease: link and potential impact on treatment 184
EFFECT OF TAT TRANSDOMINANT NEGATIVE MUTANTS ON HIV-1 REPLICATION IN JURKAT T-CELL LINES 181
Engineering herpes simplex virus vectors for CNS applications 180
null 179
Poster: Herpes simplex vaccine vector co-expressing fused Mycobacterium Tuberculosis immunogens and Tat adjuvant enhances cellular and humoral responses in Balb/c mice 179
Herpetic vectors inhibiting angiogenesis and Inducing cell suicide in gliomas 178
Constitutive crosspresentation of tissue antigens by dendritic cells controls CD8(+) T cell tolerance in vivo 177
Ethosomal Gel for Topical Administration of Dimethyl Fumarate in the Treatment of HSV-1 Infections 174
Role of Herpes Simplex Envelope Glycoprotein B and Toll-Like Receptor 2 in Ocular Inflammation: An ex vivo Organotypic Rabbit Corneal Model 174
Gene transfer to muscle using herpes simplex virus-based vectors 173
Comunicazione orale, KN: A New Vaccine Approach To Fight Mycobacterium Tuberculosis 172
The interferon-inducible IFI16 gene inhibits tube morphogenesis and proliferation of primary, but not HPV16 E6/E7-immortalized human endothelial cells 170
Herpes simplex virus type 1 (HSV-1)-derived recombinant vectors for gene transfer and gene therapy 169
Replication-defective herpes simplex virus vectors for neurotrophic factor gene transfer in vitro and in vivo 169
Viral Vector Expressing Tat As Immunomodulatory Molecule Represent A New Vaccine Strategy Against HSV Infection 168
Development of herpes simplex virus replication-defective multigene vectors for combination gene therapy applications 167
An Evaluation of Hospital Cleaning Regimes—Microbiological Evaluation and LCA Analysis after Traditional and Sustainable/Green Procedures 165
Parenchymal cells critically curtail cytotoxic T-cell responses by inducing Bim-mediated apoptosis 165
The Tat Protein of HIV-1 Prevents the Loss of HSV-Specific Memory Adaptive Responses and Favors the Control of Viral Reactivation 165
Herpes Simplex Virus ICP27 Protein Inhibits AIM 2-Dependent Inflammasome Influencing Pro-Inflammatory Cytokines Release in Human Pigment Epithelial Cells (hTert-RPE 1) 163
Progress in development of herpes simplex virus gene vectors for treatment of rheumatoid arthritis 163
Herpes Simplex Virus Type 1-Derived Recombinant and Amplicon Vectors 163
Construction of Replication Defective Herpes Simplex Virus Vectors. 163
Development of Replication-Defective Herpes Simplex Virus Vectors 163
Suppressing gain-of-function proteins via CRISPR/Cas9 system in SCA1 cells 163
Reduced immune responses after vaccination with a recombinant herpes simplex virus type 1 vector in the presence of antiviral immunity 162
Delivery to the central nervous system of a nonreplicative herpes simplex type 1 vector engineered with the interleukin 4 gene protects rhesus monkeys from hyperacute autoimmune encephalomyelitis 162
Cytokine therapy in immune-mediated demyelinating diseases of the central nervous system: a novel gene therapy approach 160
Peripheral T Cells Re-Enter the Thymus and Interfere with Central Tolerance Induction 160
Identification of replication-competent HSV-1 Cgal(+) strain targets in a mouse model of human hepatocarcinoma xenograft 160
Analysis of Civil Environments Cleaning Services—Microbiological and LCA Analysis after Traditional and Sustainable Procedures 159
Modulation of mucosal and systemic immunity by enteric administration of nonreplicating herpes simplex virus expressing cytokines 159
Capitolo 44 Herpesviridae 159
Specific targeted binding of herpes simplex virus type 1 to hepatocytes via the human hepatitis B virus preS1 peptide 158
Advances in the development of herpes simplex virus-based gene transfer vectors for the nervous system 158
Lentiviral-mediated transcriptional targeting of dendritic cells for induction of T cell tolerance in vivo 157
MHC class I cross-presentation by dendritic cells counteracts viral immune evasion 156
Cytokine gene delivery into the central nervous system using intrathecally injected nonreplicative viral vectors 155
Localized delivery of fibroblast growth factor-2 and brain-derived neurotrophic factor reduces spontaneous seizures in an epilepsy model 155
Magnolia officinalis L. bark extract and respiratory diseases: From traditional Chinese medicine to western medicine via network target 154
Connexin 43-enhanced suicide gene therapy using herpesviral vectors 153
A Safe-by-Design Approach for the Synthesis of a Novel Cross-Linked Hyaluronic Acid with Improved Biological and Physical Properties 152
Transcriptional targeting of B cells for induction of peripheral CD8 T cell tolerance 152
HSV Recombinant Vectors for Gene Therapy 151
Genetically modified CD34+ cells as cellular vehicles for gene delivery into areas of angiogenesis in a rhesus model 150
Evaluating Cleaning Services in Civil Environments: Microbiological and Life Cycle Analysis Comparing Conventional and Sustainable Methods 148
Inhibition of human immunodeficiency virus reactivation from latency by a tat transdominant negative mutant 147
Natural Polyphenol-Containing Gels against HSV-1 Infection: A Comparative Study 147
Cytokine gene therapy of autoimmune demyelination revisited using herpes simplex virus type-1-derived vectors 146
Replication-deficient mutant Herpes Simplex Virus-1 targets professional antigen presenting cells and induces efficient CD4+ T helper responses 145
Mangiferin loaded smart gels for HSV-1 treatment 144
HSV-1-mediated IL-1 receptor antagonist gene therapy ameliorates MOG35-55-induced experimental autoimmune encephalomyelitis in C57BL/6 mice 143
Deletion of multiple immediate-early genes from herpes simplex virus reduces cytotoxicity and permits long-term gene expression in neurons 143
Comunicazione orale, Keynote speaker: Herpes Simplex Vector Expressing Hiv1 Tat: A New Strategy For Vaccine Development 143
Highly differentiated T cells link systemic and vascular inflammation in a mouse model of recurrent psoriasis 137
Replication-defective herpes simplex virus vectors for gene transfer in vivo 137
High-efficacy thymidine kinase gene transfer to ovarian cancer cell lines mediated by herpes simplex virus type 1 vector 137
Chapter 8: Gene-transfer Tool: Herpes Simplex Virus Vectors 137
Rapid method for construction of recombinant HSV gene transfer vectors 137
Use of a Novel Peptide Welding Technology Platform for the Development of B- and T-Cell Epitope-Based Vaccines 137
Chapter 7 Gene Transfer to Muscle and Spinal Cord Using Herpes Simplex Virus-Based Vectors 135
Gene transfer to muscle and spinal cord using herpes simplex virus-based vectors. 135
Totale 18.122
Salva come PNG Salva come JPEG
Categoria #
all - tutte 108.084
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 16.322
Totale 124.406
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.335 0 182 75 63 53 48 94 80 61 103 134 442
2022/20231.200 147 29 63 136 159 181 47 140 172 21 73 32
2023/2024890 80 85 42 26 39 264 55 43 21 25 22 188
2024/20252.886 82 80 235 112 385 317 47 172 380 332 426 318
2025/20269.586 962 347 817 1.178 1.262 623 1.024 514 979 1.030 579 271
2026/2027497 371 126 0 0 0 0 0 0 0 0 0 0
Totale 23.641